We are live on ! Find out more
IBRX icon

ImmunityBio
IBRX

241 hedge funds and large institutions have $328M invested in ImmunityBio in 2025 Q2 according to their latest regulatory filings, with 61 funds opening new positions, 103 increasing their positions, 37 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

178% more repeat investments, than reductions

Existing positions increased: 103 | Existing positions reduced: 37

126% more first-time investments, than exits

New positions opened: 61 | Existing positions closed: 27

37% more capital invested

Capital invested by funds: $239M → $328M (+$88.5M)

15% more funds holding

Funds holding: 210 → 241 (+31)

4.74% more ownership

Funds ownership: 9.33% → 14.07% (+4.7%)

3% less call options, than puts

Call options by funds: $11.9M | Put options by funds: $12.2M

Holders
241
Holders Change
+31
Holders Change %
+14.76%
% of All Funds
3.17%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
61
Increased
103
Reduced
37
Closed
27
Calls
$11.9M
Puts
$12.2M
Net Calls
-$313K
Net Calls Change
+$5.37M

Top Buyers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
+$22.1M
2
AC
Armistice Capital
New York
+$20.9M
3
Jane Street
Jane Street
New York
+$20.4M
4
BlackRock
BlackRock
New York
+$12M
5
AC
AlphaCore Capital
California
+$8M

Top Sellers

Rank Fund Capital Flow
1
Verition Fund Management
Verition Fund Management
Connecticut
-$1.56M
2
Group One Trading
Group One Trading
Illinois
-$1.53M
3
HF
HRT Financial
New York
-$715K
4
UBS Group
UBS Group
Switzerland
-$666K
5
Citigroup
Citigroup
New York
-$612K
Name Holding Trade Value Shares
Change 		Change in
Stake
HWAM
51
Hennion & Walsh Asset Management
New Jersey
$477K +$485K +180,521 New
CUAMC
52
China Universal Asset Management Company
China
$468K +$82.9K +30,813 +21%
IIM
53
INTECH Investment Management
Florida
$438K +$91.3K +33,960 +26%
AQR Capital Management
54
AQR Capital Management
Connecticut
$420K +$308K +114,714 +258%
Deutsche Bank
55
Deutsche Bank
Germany
$419K +$127K +47,127 +42%
EAM
56
Erste Asset Management
Austria
$413K – – –
Raymond James Financial
57
Raymond James Financial
Florida
$404K +$185K +68,956 +82%
BHCM
58
Brevan Howard Capital Management
Jersey
$393K -$530K -197,233 -57%
CFO
59
Collective Family Office
Pennsylvania
$376K +$103K +38,210 +37%
VIA
60
Virtus Investment Advisers
Connecticut
$368K +$57K +21,209 +18%
Mirae Asset Global ETFs Holdings
61
Mirae Asset Global ETFs Holdings
Hong Kong
$366K +$88K +32,726 +31%
MIM
62
MetLife Investment Management
New Jersey
$365K +$199K +74,106 +116%
Invesco
63
Invesco
Georgia
$344K +$53.8K +20,013 +18%
WE
64
Wealth Effects
Massachusetts
$322K +$63.2K +23,500 +24%
Manulife (Manufacturers Life Insurance)
65
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$321K +$49.1K +18,278 +18%
Janus Henderson Group
66
Janus Henderson Group
United Kingdom
$313K +$158K +58,899 +98%
SS
67
SBI Securities
Japan
$312K +$283K +105,292 +824%
RG
68
Rathbones Group
United Kingdom
$310K +$55.9K +20,800 +22%
T. Rowe Price Associates
69
T. Rowe Price Associates
Maryland
$304K +$131K +48,896 +74%
BRWA
70
B. Riley Wealth Advisors
Florida
$298K +$304K +113,000 New
RFC
71
Regions Financial Corp
Alabama
$269K +$274K +102,000 New
KA
72
Kercheville Advisors
Texas
$265K +$270K +100,500 New
MIC
73
Meridian Investment Counsel
California
$255K – – –
Handelsbanken Fonder
74
Handelsbanken Fonder
Sweden
$253K +$9.95K +3,700 +4%
Franklin Resources
75
Franklin Resources
California
$230K +$234K +87,141 New
1 2
3
4 5

IBRX Hedge Fund Activity: Q2 2025 in Review

241 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in ImmunityBio (IBRX) for Q2 2025, worth a combined $328M — up 37% from $239M a quarter earlier.

Buyers outnumbered sellers: 61 funds opened new IBRX positions and 27 closed out — a net gain of 34 holders — while 103 added to existing stakes and 37 trimmed.

The largest buyer was Bank of America, adding an estimated $22.1M. The largest seller was Verition Fund Management, cutting an estimated $1.56M.

  • 241 institutional investors held ImmunityBio (IBRX) as of Q2 2025, up from 210 in Q1 2025.
  • Funds reported $328M of ImmunityBio stock for Q2 2025, up 37% quarter-over-quarter.
  • 61 funds opened new ImmunityBio positions in Q2 2025 and 27 closed out, a net change of +34 holders.
  • The largest ImmunityBio buyer in Q2 2025 was Bank of America, an estimated $22.1M added.
  • The largest ImmunityBio seller in Q2 2025 was Verition Fund Management, an estimated $1.56M sold.

Based on aggregated 13F filings for Q2 2025.